BusinessZealand announces that Sanofi's NDA for the fixed-ratio combination (LixiLan) of lixisenatide and insulin glargine for Type 2 diabetes has been accepted for review by the FDABy Nasdaq OMXFeb 22, 2016, 6:28 AM UTC
BusinessLeading Beverly Hills Plastic Surgeon Dr. Payman Simoni Joins CBS’ “The Doctors” for a Special SegmentBy Nasdaq OMXFeb 19, 2016, 6:09 PM UTC
BusinessSurgery Partners, Inc. Announces Fourth Quarter and Full Year 2015 Earnings Release Date and Conference Call DetailsBy Nasdaq OMXFeb 18, 2016, 9:00 PM UTC
Business3B Medical Selects Vodafone to Deliver Sleep Data WirelesslyBy Nasdaq OMXFeb 17, 2016, 11:53 PM UTC
BusinessGifts of life: Two families share joy and pain after rare double-lung and heart transplantBy Nasdaq OMXFeb 17, 2016, 4:47 PM UTC
BusinessINC Research Launches Catalyst Program to Strengthen Collaboration With Clinical Research Sites, Enhance Delivery to CustomersBy Nasdaq OMXFeb 17, 2016, 3:46 PM UTC
BusinessK2M Group Holdings, Inc. to Release Fourth Quarter and Fiscal Year 2015 Financial Results on March 3rdBy Nasdaq OMXFeb 17, 2016, 12:30 PM UTC
BusinessCuris to Present at the 2016 RBC Capital Markets Global Healthcare ConferenceBy Nasdaq OMXFeb 17, 2016, 12:00 PM UTC